Cargando…
Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
Autores principales: | Beuers, Ulrich, Oude Elferink, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606833/ https://www.ncbi.nlm.nih.gov/pubmed/36096210 http://dx.doi.org/10.1016/j.jcmgh.2022.08.009 |
Ejemplares similares
-
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019) -
Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis
por: Qiu, Han, et al.
Publicado: (2022) -
Primary biliary cirrhosis
por: Hohenester, Simon, et al.
Publicado: (2009) -
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022) -
Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Keune, Willem-Jan, et al.
Publicado: (2016)